What were you expecting? A split vote, even the yes votes were rather negative in their comments, and Hana has no money to complete the required P3 trial which will likely cost north of $50M and take 5 years, at least. Plus, much better treatments (blinatumomab) will be hitting the market within the year, pretty much destroying many of the conventional ALL drugs. Even if AA is granted, this is dead money.
Re: hummerSympson is a paid basher 20-Mar-12 12:44 pm you're half right, definitely a basher but not paid. No position in Hana/Tlon at all, but did lose money on it last year and would like to keep others from doing the same.
Let me make you an offer though. If the ODAC is positive tomorrow, I will post here and praise your intellect and stock savy and admit I was a moron for doubting the Marqibo story. If it is negative, will you do the same?